Sabra Healthcare REIT (NASDAQ:SBRA) Rating Lowered to Sell at Wall Street Zen

Sabra Healthcare REIT (NASDAQ:SBRA) was downgraded by research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a note issued to investors on Friday.

A number of other equities research analysts have also recently issued reports on the company. Jefferies Financial Group restated a “buy” rating and issued a $22.00 price objective on shares of Sabra Healthcare REIT in a research note on Monday, December 15th. National Bankshares set a $22.00 price target on shares of Sabra Healthcare REIT in a research report on Friday, October 17th. Truist Financial upped their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “hold” rating in a research note on Tuesday, January 20th. Cantor Fitzgerald began coverage on shares of Sabra Healthcare REIT in a research note on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 price objective for the company. Finally, UBS Group assumed coverage on shares of Sabra Healthcare REIT in a report on Tuesday, November 18th. They set a “neutral” rating and a $20.00 target price on the stock. Four research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $21.11.

Sabra Healthcare REIT Price Performance

Sabra Healthcare REIT stock opened at $18.82 on Friday. The business’s 50 day simple moving average is $19.05 and its 200 day simple moving average is $18.70. Sabra Healthcare REIT has a 12 month low of $15.60 and a 12 month high of $19.97. The company has a market cap of $4.69 billion, a price-to-earnings ratio of 26.14, a PEG ratio of 1.31 and a beta of 0.67. The company has a current ratio of 5.19, a quick ratio of 5.19 and a debt-to-equity ratio of 0.92.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.01. Sabra Healthcare REIT had a return on equity of 6.38% and a net margin of 23.50%.The firm had revenue of $190.04 million for the quarter, compared to analyst estimates of $193.44 million. During the same period in the previous year, the company posted $0.37 earnings per share. The business’s revenue was up 6.7% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. Sell-side analysts forecast that Sabra Healthcare REIT will post 1.45 EPS for the current year.

Institutional Investors Weigh In On Sabra Healthcare REIT

A number of institutional investors and hedge funds have recently made changes to their positions in SBRA. Founders Capital Management purchased a new position in Sabra Healthcare REIT during the third quarter worth about $28,000. Danske Bank A S bought a new stake in shares of Sabra Healthcare REIT during the 3rd quarter valued at about $30,000. Larson Financial Group LLC grew its holdings in shares of Sabra Healthcare REIT by 42.3% during the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after purchasing an additional 553 shares in the last quarter. Covestor Ltd grew its holdings in shares of Sabra Healthcare REIT by 23,720.0% during the third quarter. Covestor Ltd now owns 2,382 shares of the real estate investment trust’s stock worth $45,000 after purchasing an additional 2,372 shares in the last quarter. Finally, EverSource Wealth Advisors LLC increased its position in shares of Sabra Healthcare REIT by 150.7% in the second quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock worth $47,000 after purchasing an additional 1,536 shares during the last quarter. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.